Because the results of the present study that Ipriflavone downregulated the KIAA mediated HA degrading activity and suppressed MMP1 and MMP3 in FLS stimulated with TNF-α, Ipriflavone may partially contribute to the improvement of synovial inflammation and may be an option to support the treatment of RA. This evidence concerns the gene MMP1 and rheumatoid arthritis.